These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27097498)

  • 41. Leukocytes as modulators of stellate cell activation.
    Maher JJ
    Alcohol Clin Exp Res; 1999 May; 23(5):917-21. PubMed ID: 10371414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Advances in the regulatory roles of exosomes on pathological process of schistosomiasis hepatic fibrosis].
    Yong-Hua Z; Xian-Shi T; Li-Juan S; Xuan D; Ke W; Jun-Qi Y; Yong-Liang X
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2018 May; 30(5):596-600. PubMed ID: 30567043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD14-positive hepatic monocytes/macrophages increase in hereditary hemochromatosis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2004 Oct; 24(5):446-51. PubMed ID: 15482341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic Fibrosis in a Long-term Murine Model of Sepsis.
    Gonnert FA; Kunisch E; Gajda M; Lambeck S; Weber M; Claus RA; Bauer M; Kinne RW
    Shock; 2012 Apr; 37(4):399-407. PubMed ID: 22266973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
    Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
    J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic fibrosis, stellate cells, and portal hypertension.
    Rockey DC
    Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
    Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
    Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Th17 cells regulate liver fibrosis by targeting multiple cell types: many birds with one stone.
    Gao B; Waisman A
    Gastroenterology; 2012 Sep; 143(3):536-539. PubMed ID: 22842060
    [No Abstract]   [Full Text] [Related]  

  • 50. Inflammation and hepatic fibrosis.
    Bissell DM
    Semin Liver Dis; 2010 Aug; 30(3):211-4. PubMed ID: 20665373
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytokines and fibrogenesis.
    Friedman SL
    Semin Liver Dis; 1999; 19(2):129-40. PubMed ID: 10422196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracellular signaling pathways in stellate cell activation.
    Britton RS; Bacon BR
    Alcohol Clin Exp Res; 1999 May; 23(5):922-5. PubMed ID: 10371415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Liver fibrogenesis: physiopathology].
    Odena G; Bataller R
    Gastroenterol Hepatol; 2012 Dec; 35 Suppl 2():3-9. PubMed ID: 23298653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic stellate cells and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-matrix interactions in schistosomal portal fibrosis: a dynamic event.
    Grimaud JA
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():55-65. PubMed ID: 3334433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica.
    Zhang Y; Huang D; Gao W; Yan J; Zhou W; Hou X; Liu M; Ren C; Wang S; Shen J
    Int Immunol; 2015 Jul; 27(7):317-25. PubMed ID: 25840437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver fibrosis.
    Wallace K; Burt AD; Wright MC
    Biochem J; 2008 Apr; 411(1):1-18. PubMed ID: 18333835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New surprises of suppressor of cytokine signalling in liver fibrosis.
    Cheng C; Huang C; Ma TT; Xu T; Wang YR; Zhang L; Jun L
    Expert Opin Ther Targets; 2014 Apr; 18(4):415-26. PubMed ID: 24597641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.